BRAGE MEDICAL AS

3057 SOLBERGELVA

Finances

Share Ownership

Return on Equity

64,5 %

Current Ratio

2,15

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	40 915 000	39 653 000	49 241 000	28 147 000
Net Income	6 235 000	7 108 000	10 344 000	4 437 000
Total Assets	17 954 000	17 359 000	21 631 000	11 761 000
Total Equity	9 667 000	9 432 000	8 324 000	5 480 000

Income (NOK)	2022	2021	2020	2019
Revenue	40 915 000	39 653 000	49 241 000	28 147 000
Expenditure	32 871 000	30 464 000	35 810 000	22 366 000
Operating Profit	8 045 000	9 189 000	13 432 000	5 781 000
Financial Income	146 000	52 000	88 000	44 000
Financial Costs	165 000	118 000	256 000	120 000
Financial Balance	−19 000	−66 000	−168 000	−76 000
Earnings Before Tax	8 026 000	9 123 000	13 263 000	5 705 000
Tax	1 791 000	2 015 000	2 919 000	1 267 000
Net Income	6 235 000	7 108 000	10 344 000	4 437 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	147 000	73 000	35 000	35 000
Total Current Assets	17 807 000	17 286 000	21 596 000	11 726 000
Total Assets	17 954 000	17 359 000	21 631 000	11 761 000
Total Retained Equity	9 567 000	9 332 000	8 224 000	5 380 000
Total Equity	9 667 000	9 432 000	8 324 000	5 480 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	8 287 000	7 927 000	13 307 000	6 281 000
Total Equity and Debt	17 954 000	17 359 000	21 631 000	11 761 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	40 915 000	39 653 000	49 241 000	28 147 000
Other Income	0	0	0	0
Revenue	40 915 000	39 653 000	49 241 000	28 147 000
Cost of Goods Sold	24 336 000	23 273 000	29 022 000	16 900 000
Salary Costs	6 477 000	5 657 000	5 303 000	3 914 000
Depreciation	52 000	23 000	20 000	26 000
Impairment	0	0	0	0
Expenditure	32 871 000	30 464 000	35 810 000	22 366 000
Operating Profit	8 045 000	9 189 000	13 432 000	5 781 000
Financial Income	146 000	52 000	88 000	44 000
Financial Costs	165 000	118 000	256 000	120 000
Financial Balance	−19 000	−66 000	−168 000	−76 000
Dividends	3 000 000	0	4 500 000	3 000 000
Net Income	6 235 000	7 108 000	10 344 000	4 437 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	147 000	73 000	35 000	35 000
Total Tangible Assets	147 000	73 000	35 000	35 000
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	147 000	73 000	35 000	35 000
Stock	8 405 000	6 396 000	6 572 000	3 977 000
Total Investments	0	0	0	0
Cash, Bank	5 093 000	5 309 000	10 151 000	4 776 000
Total Current Assets	17 807 000	17 286 000	21 596 000	11 726 000
Total Assets	17 954 000	17 359 000	21 631 000	11 761 000
Total Equity	9 667 000	9 432 000	8 324 000	5 480 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	550 000	227 000	2 999 000	110 000
Unpaid Taxes	1 757 000	1 842 000	2 030 000	1 299 000
Dividends	3 000 000	0	4 500 000	3 000 000
Other Current Debt	1 189 000	843 000	859 000	604 000
Total Current Debt	8 287 000	7 927 000	13 307 000	6 281 000
Total Equity and Debt	17 954 000	17 359 000	21 631 000	11 761 000

Financial indicators	2022	2021	2020	2019
Return on Equity	64,5 %	75,36 %	124,27 %	80,97 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	19,66 %	23,17 %	27,28 %	20,54 %
Current Ratio	2,15	2,18	1,62	1,87
Quick Ratio	−150,91	11,29	3,21	5,09
Equity Ratio	0,54	0,54	0,38	0,47
Gross Profit Margin	40,52 %	41,31 %	41,06 %	39,96 %